Daunorubicin and Cytarabine (Liposomal) and Dexrazoxane Intravenous
Determining the interaction of Daunorubicin and Cytarabine (Liposomal) and Dexrazoxane Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cytarabine liposomal / daunorubicin liposomal
Brand name: Vyxeos
Synonyms: Cytarabine and daunorubicin (liposomal)
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daunorubicin and Cytarabine (Liposomal)-Dextenza Insert
- Daunorubicin and Cytarabine (Liposomal)-Dextenza intraocular
- Daunorubicin and Cytarabine (Liposomal)-Dextran 40
- Daunorubicin and Cytarabine (Liposomal)-Dextran 70 6% in 5% Dextrose high molecular weight
- Daunorubicin and Cytarabine (Liposomal)-Dextran 75
- Daunorubicin and Cytarabine (Liposomal)-Dextran high molecular weight
- Dexrazoxane Intravenous-Daunorubicin and cytarabine liposome Intravenous
- Dexrazoxane Intravenous-Daunorubicin citrate
- Dexrazoxane Intravenous-Daunorubicin citrate liposome Intravenous
- Dexrazoxane Intravenous-Daunorubicin hydrochloride
- Dexrazoxane Intravenous-Daunorubicin Intravenous
- Dexrazoxane Intravenous-DaunoXome